ImmunoGen, Inc. Free Cash Flow 2010-2023 | IMGN
ImmunoGen, Inc. free cash flow from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| ImmunoGen, Inc. Annual Free Cash Flow |
| 2022 |
-231.17 |
| 2021 |
-170.85 |
| 2020 |
-78.11 |
| 2019 |
-88.90 |
| 2018 |
-171.67 |
| 2017 |
6.53 |
| 2016 |
|
| 2016 |
-134.85 |
| 2015 |
-62.72 |
| 2014 |
-61.83 |
| 2013 |
-64.07 |
| 2012 |
-37.20 |
| 2011 |
-10.02 |
| 2010 |
-42.12 |
| 2009 |
-15.23 |
| ImmunoGen, Inc. Quarterly Free Cash Flow |
| 2023-09-30 |
-139.33 |
| 2023-06-30 |
-140.75 |
| 2023-03-31 |
-73.93 |
| 2022-12-31 |
-231.17 |
| 2022-09-30 |
-170.72 |
| 2022-06-30 |
-105.91 |
| 2022-03-31 |
-41.71 |
| 2021-12-31 |
-170.85 |
| 2021-09-30 |
-124.61 |
| 2021-06-30 |
-89.44 |
| 2021-03-31 |
-45.51 |
| 2020-12-31 |
-78.11 |
| 2020-09-30 |
-86.54 |
| 2020-06-30 |
-55.13 |
| 2020-03-31 |
-26.91 |
| 2019-12-31 |
-88.90 |
| 2019-09-30 |
-58.57 |
| 2019-06-30 |
-23.17 |
| 2019-03-31 |
8.08 |
| 2018-12-31 |
-171.67 |
| 2018-09-30 |
-129.36 |
| 2018-06-30 |
-87.41 |
| 2018-03-31 |
-50.98 |
| 2017-12-31 |
6.53 |
| 2017-09-30 |
36.21 |
| 2017-06-30 |
-9.66 |
| 2017-03-31 |
-33.40 |
| 2016-12-31 |
|
| 2016-09-30 |
-113.26 |
| 2016-06-30 |
-134.85 |
| 2016-03-31 |
-29.56 |
| 2015-12-31 |
-70.62 |
| 2015-09-30 |
-34.73 |
| 2015-06-30 |
|
| 2015-03-31 |
-31.34 |
| 2014-12-31 |
-36.97 |
| 2014-09-30 |
-20.61 |
| 2014-06-30 |
|
| 2014-03-31 |
-39.44 |
| 2013-12-31 |
-23.93 |
| 2013-09-30 |
-24.15 |
| 2013-06-30 |
|
| 2013-03-31 |
-51.10 |
| 2012-12-31 |
-44.75 |
| 2012-09-30 |
-21.97 |
| 2012-06-30 |
|
| 2012-03-31 |
-19.90 |
| 2011-12-31 |
-24.87 |
| 2011-09-30 |
-12.12 |
| 2011-06-30 |
|
| 2011-03-31 |
4.41 |
| 2010-12-31 |
17.52 |
| 2010-09-30 |
-15.63 |
| 2010-06-30 |
|
| 2010-03-31 |
-31.98 |
| 2009-12-31 |
-21.15 |
| 2009-09-30 |
-12.04 |
| 2009-06-30 |
|
| 2009-03-31 |
-4.49 |
